{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:15:30Z","timestamp":1780503330697,"version":"3.54.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.semnephrol.2021.03.006","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T16:09:30Z","timestamp":1623686970000},"page":"114-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Testosterone Disorders and Male Hypogonadism in Kidney Disease"],"prefix":"10.1016","volume":"41","author":[{"given":"Giacomo","family":"Garibotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Picciotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Verzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2021.03.006_bib0001","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1093\/ndt\/gfs383","article-title":"The vulnerable man: impact of testosterone deficiency on the uraemic phenotype","volume":"27","author":"Carrero","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0002","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.ajkd.2014.03.010","article-title":"Serum testosterone level and mortality in men with CKD stages 3-4","volume":"64","author":"Khurana","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0003","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1681\/ASN.2008060664","article-title":"Low serum testosterone increases mortality risk among male dialysis patients","volume":"20","author":"Carrero","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0004","first-page":"15","article-title":"Testosterone action, deficiency, substitution","author":"Nieschlag","year":"2012","journal-title":"Cambridge, United Kingdom: Cambridge University Press, Cambridge, UK"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0005","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0006","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","article-title":"Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging","volume":"86","author":"Harman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0007","doi-asserted-by":"crossref","first-page":"E284","DOI":"10.1152\/ajpendo.00334.2001","article-title":"Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men","volume":"283","author":"Roy","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0008","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/13685538.2012.705366","article-title":"Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"15","author":"Eichholzer","year":"2012","journal-title":"Aging Male"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0009","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2605.2012.01285.x","article-title":"Clinical correlates of sex steroids and gonadotropins in men over the late adulthood: the Framingham Heart Study","volume":"35","author":"Haring","year":"2012","journal-title":"Int J Androl"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0010","first-page":"1","article-title":"Gender and progression of chronic kidney disease: does apoptosis make the difference?","volume":"56","author":"Gandolfo","year":"2004","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0011","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1681\/ASN.V112319","article-title":"Effect of gender on the progression of nondiabetic renal disease: a meta-analysis","volume":"11","author":"Neugarten","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0012","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneph.2017.181","article-title":"Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease","volume":"14","author":"Carrero","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0013","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1681\/ASN.2015080886","article-title":"Sex differences in renal proximal tubular cell homeostasis","volume":"27","author":"Seppi","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0014","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1111\/j.1523-1755.2004.66005.x","article-title":"Estradiol reverses renal injury in Alb\/TGF-beta1 transgenic mice","volume":"66","author":"Blush","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0015","doi-asserted-by":"crossref","first-page":"R1057","DOI":"10.1152\/ajpregu.00417.2015","article-title":"Sex and gender differences in cardiovascular, renal and metabolic diseases","volume":"309","author":"Reckelhoff","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0016","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/157339911794273982","article-title":"Estrogens and progression of diabetic kidney damage","volume":"7","author":"Doublier","year":"2011","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0017","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/sj.ki.5001880","article-title":"Gender differences in renal nuclear receptors and aryl hydrocarbon receptor in 5\/6 nephrectomized rats","volume":"70","author":"Lu","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0018","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1523-1755.2004.00497.x","article-title":"Testosterone promotes apoptotic proximal tubule damage in human renal tubular cells.","volume":"65","author":"Verzola","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0019","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbrc.2009.07.056","article-title":"Androgen-mediated apoptosis of kidney tubule cells: role of c-Jun amino terminal kinase","volume":"387","author":"Verzola","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0020","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/10408444.2020.1789944","article-title":"Effectiveness of testosterone therapy in hypogonadal patients and its controversial adverse impact on the cardiovascular system.","volume":"50","author":"Kharaba","year":"2020","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0021","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/cen.12452","article-title":"Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study","volume":"81","author":"Shores","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0022","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","article-title":"Using human genetics to understand the disease impacts of testosterone in men and women","volume":"26","author":"Ruth","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0023","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.ackd.2004.07.004","article-title":"The hypothalamic-pituitary axis in men and women with chronic kidney disease","volume":"4","author":"Holley","year":"2004","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0024","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ki.1997.109","article-title":"Circulating luteinizing hormone receptor inhibitor(s) in boys with chronic renal failure","volume":"51","author":"Dunkel","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0025","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.2215\/CJN.03600410","article-title":"Endogenous testosterone and mortality in male hemodialysis patients: is it the result of aging?","volume":"5","author":"Gungor","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0026","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1093\/ndt\/gfq847","article-title":"Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients","volume":"26","author":"Kyriazis","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0027","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.ajkd.2013.06.010","article-title":"Serum testosterone levels and clinical outcomes in male hemodialysis patients","volume":"63","author":"Bello","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0028","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2265.2008.03455.x","article-title":"Endogenous sex steroid hormones and measures of chronic kidney disease in a nationally representative sample of men","volume":"71","author":"Yi","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0029","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/er.2004-0013","article-title":"The decline of androgen levels in elderly men and its clinical and therapeutic implications","volume":"26","author":"Kaufman","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0030","doi-asserted-by":"crossref","first-page":"32.","DOI":"10.3389\/fmed.2017.00032","article-title":"Male sexual dysfunction and chronic kidney disease","volume":"4","author":"Edey","year":"2017","journal-title":"Front Med"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0031","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2215\/CJN.10681210","article-title":"Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease","volume":"6","author":"Yilmaz","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0032","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10157-012-0652-0","article-title":"Relationship between total testosterone, cognitive function, depressive behavior, and sleep quality in chronic kidney disease patients not on dialysis","volume":"17","author":"Afsar","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0033","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000324562","article-title":"Low serum testosterone is associated with increased mortality in men with stage 3 or greater nephropathy","volume":"33","author":"Haring","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0034","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.juro.2014.03.102","article-title":"Low testosterone at time of transplant is independently associated with poor patient and graft survival in male renal transplant recipients","volume":"192","author":"Shoskes","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0035","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s40620-018-0513-3","article-title":"Testosterone in renal transplant patients: effect on body composition and clinical parameters","volume":"31","author":"Lofaro","year":"2018","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0036","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00467-016-3432-3","article-title":"Pubertal development in children with chronic kidney disease.","volume":"32","author":"Haffner","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0037","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1523-1755.2003.00042.x","article-title":"Association of decreased quality of life and erectile dysfunction in hemodialysis patients","volume":"64","author":"Rosas","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0038","doi-asserted-by":"crossref","first-page":"c21","DOI":"10.1159\/000075568","article-title":"Quality of life in male hemodialysis patients. Role of erectile dysfunction","volume":"96","author":"T\u00fcrk","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0039","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/ndt\/gfr288","article-title":"Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease","volume":"27","author":"Carrero","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0040","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ekir.2018.01.009","article-title":"Bioavailable testosterone is positively associated with bone mineral density in male kidney transplantation candidates","volume":"3","author":"J\u00f8rgensen","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0041","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1095\/biolreprod.107.063545","article-title":"Testosterone reduces macrophage expression in the mouse of Toll-like receptor 4, a trigger for inflammation and innate immunity","volume":"78","author":"Rettew","year":"2008","journal-title":"Biol Reprod"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0042","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.ekir.2017.07.015","article-title":"Testosterone and all-cause mortality and infection-related hospitalization in male hemodialysis patients: a prospective cohort study","volume":"2","author":"Nakashima","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"11","key":"10.1016\/j.semnephrol.2021.03.006_bib0043","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13293-020-00330-7","article-title":"Sex differences in severity and mortality from COVID-19: are males more vulnerable?","author":"Pradhan","year":"2020","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0044","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3390\/ijerph8051631","article-title":"Protein-energy wasting and mortality in chronic kidney disease","volume":"8","author":"Bonanni","year":"2011","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.jrn.2017.11.002","article-title":"Prevalence and risk of protein-energy wasting assessed by subjective global assessment in older adults with advanced chronic kidney disease: results from the EQUAL study","volume":"28","author":"Windahl","year":"2018","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0046","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.jrn.2019.09.005","article-title":"Improving muscle strength and preventing sarcopenia and cachexia in chronic kidney disease and transplanted patients by physical activity and exercise","volume":"29","author":"Kalantar-Zadeh","year":"2019","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0047","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/ndt\/gfaa072","article-title":"Muscle protein turnover and low-protein diets in patients with chronic kidney disease","volume":"35","author":"Garibotto","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0048","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1681\/ASN.2019121277","article-title":"Mechanisms regulating muscle protein synthesis in chronic kidney disease","volume":"31","author":"Zhang","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12986-019-0385-0","article-title":"Acute testosterone administration does not affect muscle anabolism","volume":"16","author":"Church","year":"2019","journal-title":"Nutr Metab"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0050","first-page":"E864","article-title":"Testosterone injection stimulates net protein synthesis but not tissue amino acid transport","volume":"275","author":"Ferrando","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0051","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/bjp.2008.165","article-title":"Pharmacology of anabolic steroids","volume":"154","author":"Kicman","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0052","article-title":"Effects of long term supplementation of anabolic androgen steroids on human skeletal muscle","volume":"9","author":"Yu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0053","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1053\/j.jrn.2012.08.007","article-title":"Endogenous testosterone, muscle strength, and fat-free mass in men with chronic kidney disease","volume":"23","author":"Cigarr\u00e1n","year":"2013","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0054","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/j.jrn.2019.03.078","article-title":"Lean tissue index and body cell mass can be predictors of low free testosterone levels in men on hemodialysis","volume":"29","author":"Rymarz","year":"2019","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0055","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/ndt\/gfy252","article-title":"Low testosterone is associated with frailty, muscle wasting, and physical dysfunction among men receiving hemodialysis: a longitudinal analysis","volume":"34","author":"Chiang","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0056","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.jrn.2014.10.018","article-title":"Endocrine and metabolic changes affecting cardiovascular disease in dialysis patients","volume":"25","author":"Shoji","year":"2015","journal-title":"J Ren Nut"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0057","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jamda.2013.03.022","article-title":"Frailty consensus: a call to action","volume":"14","author":"Morley","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0058","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/geriatrics2010006","article-title":"Systemic inflammation in the genesis of frailty and sarcopenia: an overview of the preventative and therapeutic role of exercise and the potential for drug treatments","volume":"2","author":"Allen","year":"2017","journal-title":"Geriatrics"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0059","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1447-0594.2011.00797.x","article-title":"Screening tools for frailty in primary health care: a systematic review","volume":"12","author":"Pialoux","year":"2012","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0060","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000452499","article-title":"Testosterone deficiency and testosterone treatment in older men","volume":"63","author":"Saad","year":"2017","journal-title":"Gerontology"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0061","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/ndt\/gfv122","article-title":"Muscle wasting in end-stage renal disease promulgates premature death: established, emerging and potential novel treatment strategies","volume":"31","author":"Stenvinkel","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0062","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2215\/CJN.02870313","article-title":"Kidney function and prevalent and incident frailty","volume":"8","author":"Dalrymple","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0063","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/jgs.12835","article-title":"Androgen deficiency as a biological determinant of frailty: hope or hype?","volume":"62","author":"Afilalo","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0064","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2215\/CJN.12131116","article-title":"Factors associated with frailty and its trajectory among patients on hemodialysis","volume":"12","author":"Johansen","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2040622319880382","article-title":"Contributors, risk associates, and complications of frailty in patients with chronic kidney disease: a scoping review","volume":"10","author":"Wu","year":"2019","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0067","doi-asserted-by":"crossref","first-page":"H522","DOI":"10.1152\/ajpheart.00745.2017","article-title":"Modulatory influence of sex hormones on vascular aging","volume":"316","author":"Moreau","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0066","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.107.719005","article-title":"Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study","volume":"116","author":"Khaw","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0068","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehq009","article-title":"Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79","volume":"31","author":"Haring","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0069","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/cen.13089","article-title":"Neutral associations of testosterone, dihydrotestosterone and estradiol with fatal and nonfatal cardiovascular events, and mortality in men aged 17\u201397 years","volume":"85","author":"Chan","year":"2016","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0070","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1210\/jc.2013-3576","article-title":"Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study","volume":"99","author":"Shores","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0071","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41569-019-0211-4","article-title":"Testosterone replacement therapy and cardiovascular risk","volume":"16","author":"Gagliano-Juc\u00e1","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0072","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.nefro.2017.03.014","article-title":"Testosterone deficiency in dialysis patients: difference between dialysis techniques","volume":"37","author":"Cigarr\u00e1n","year":"2017","journal-title":"Nefrologia"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0073","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1440-1797.2011.01520.x","article-title":"Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis","volume":"17","author":"van Eps","year":"2012","journal-title":"Nephrology"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0074","first-page":"407","article-title":"Testosterone replacement increases fat-free mass and muscle size in hypogonadal men","volume":"82","author":"Bhasin","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0075","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/570413","article-title":"Effects of low-dose testosterone undecanoate treatment on bone mineral density and bone turnover markers in elderly male osteoporosis with low serum testosterone","volume":"2013","author":"Wang","year":"2013","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0076","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/13685538.2013.773420","article-title":"Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study","volume":"16","author":"Bouloux","year":"2013","journal-title":"Aging Male"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0077","doi-asserted-by":"crossref","DOI":"10.1177\/1557988320917258","article-title":"Effects of testosterone treatment on quality of life in patients with chronic kidney disease","volume":"14","author":"Yeo","year":"2020","journal-title":"Am J Mens Health"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0078","first-page":"3578","article-title":"Testosterone replacement therapy improves mood in hypogonadal men-a clinical research center study","volume":"81","author":"Wang","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0079","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1532-5415.2006.00938.x","article-title":"Androgen treatment and muscle strength in elderly men: a meta-analysis","volume":"54","author":"Ottenbacher","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0080","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jama.281.14.1275","article-title":"Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial","volume":"281","author":"Johansen","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0081","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1681\/ASN.2006010034","article-title":"Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial","volume":"17","author":"Johansen","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0082","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2215\/CJN.00380112","article-title":"Effect of oral anabolic steroid on muscle strength and muscle growth in hemodialysis patients","volume":"8","author":"Supasyndh","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0083","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.nefro.2016.01.010","article-title":"Treatment of the testosterone deficiency in hemodialysis patients. Preliminary results","volume":"36","author":"Pampa Saico","year":"2016","journal-title":"Nefrologia"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0084","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1177\/1557988318772734","article-title":"Efficacy of testosterone treatment in hemodialysis patients as assessed by aging males\u2019 symptoms scores: a pilot study","volume":"12","author":"Inoue","year":"2018","journal-title":"Am J Mens Health"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0085","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s11914-018-0483-3","article-title":"Gonadal hormones in the pathogenesis and treatment of bone health in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"16","author":"Aleksova","year":"2018","journal-title":"Osteoporos Rep"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0086","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.amjmed.2016.09.017","article-title":"Cardiovascular risks of exogenous testosterone use among men: a systematic review and meta-analysis","volume":"130","author":"Alexander","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0087","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0088","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/er.2017-00234","article-title":"Lessons from the testosterone trials","volume":"39","author":"Snyder","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0089","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrurol.2015.238","article-title":"The practical management of testosterone deficiency in men","volume":"12","author":"Aversa","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.semnephrol.2021.03.006_bib0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and management of testosterone deficiency: AUA guideline","volume":"200","author":"Mulhall","year":"2018","journal-title":"J Urol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929521000371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929521000371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:39:23Z","timestamp":1759448363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929521000371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0270929521000371"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2021.03.006","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testosterone Disorders and Male Hypogonadism in Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2021.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}